Skip to main content
. 2013 Feb 25;8(2):e57143. doi: 10.1371/journal.pone.0057143

Table 3. EDIPS cases identified by FINDRISC10 and high risk cut-points for fasting plasma glucose (FPG) and glycated Haemoglobin (HbA1c) as specified by NICE, ADA and WHO with risk statistics for intervention and control groups compared.

FINDRISC score cut-points
Moderate or greater risk (≥12) High or greater risk (≥15)
FINDRISC a score only
EDIPS cases n (%) 519 (69·3) 330 (44·1)
Hazard ratio (95% CI), P value and B(SE) for intervention/control incidence 0·43 (0·28 to 0.66) 0·30 (0·20 to 0·51)
P<0·001–0.8(0.2) P<0·001 −1.2(0.3)
FPG (mmoll 1 )
NICE high risk range (5·5 to 6·9)
EDIPS cases n (%) 354 (49·4) 224 (31·2)
Hazard ratio (95% CI), P value and B(SE) for intervention/control incidence 0·48 (0·28 to 0·83) 0·39 (0·20 to 0·78)
P = 0·008 −0.9(0.4) P = 0·008 −0.9(0.4)
ADA high risk range (5·6 to 6·9)
EDIPS cases n (%) 328 (45·7) 209 (29·1)
Hazard ratio (95% CI), P value and B(SE) for intervention/control incidence 0·51 (0.30 to 0.87) 0·41 (0·21 to 0·83)
P = 0·014 −0.7(0.3) P = 0·007 −0.9(0.4)
WHO high risk range (6·1 to 6·9)
EDIPS cases n (%) 198 (27·6) 62 (8·9)
Hazard ratio (95% CI), P value and B(SE) for intervention/control incidence 0·37 (0.23 to 0.64) 0·31 (0·13 to 0·73)
P = 0·003 −1.0(0.3) P = 0·007 −0.9(0.4)
HbA1c b (%)
NICE and UK-NSC high risk range (6·0 to 6·4)
EDIPS cases n (%) 96 (13·7) 62 (8·9)
Hazard ratio (95% CI) P value and B(SE) for intervention/control incidence 0·46 (0·19 to 1·10) 0·35 (0·12 to 1·00)
P = 0·08 −0.8(0.4) P = 0·05 −1.1(0.5)
ADA high risk range
EDIPS cases n (%) 227 (32·4) 158 (22·6)
Hazard ratio (95% CI),P value and B(SE) for intervention/control incidence 0·43 (0·24 to 0·76) 0·28 (0·13 to 0·59)
P = 0·004 −0.8(0.3) P = 0·001 (−1.2(0.4)
a

n = 717.

b

n = 732.